As we have previously reported, the use of Pradaxa has been linked to serious injury.  There are nearly 600 lawsuits pending in federal court.  The Multi District Litigation (MDL), centralized in a Chicago federal court, continues to move forward.  The next Status Conference in the Pradaxa litigation has been schedule for the middle of May.

Trials are currently scheduled for August 2014 through February 2015.  The court presiding over the Pradaxa litigation continues to take an active role in the prompt and efficient resolution of the cases.

The devastating consequences of Pradaxa use will likely continue. If you or a loved one has experienced serious side effects after taking Pradaxa, you can contact Stark & Stark and speak to one of the Mass Tort attorneys, free of charge, who can help assess any claims that you might have against Boehringer Ingelheim Pharmaceuticals, Inc.